The Reno - Protective Effect of Intraoperative Dexmedetomidine Infusion in Elective Coronary Bypass Graft Surgery
Article Sidebar
Main Article Content
Abstract
Background: Acute kidney injury (AKI) is a common and serious complication after cardiac surgery which increase morbidity and mortality. Dexmedetomidinehas significant sympatholytic properties and ameliorating stress response. We hypothesized that dexme-detomidinecan prevent acute kidney injury in patients undergoing elective CABG.
Methods: This study was double-blinded, randomized controlled trial. Elective CABG patients with normal renal function were allocated todexmedetomidine (dexmed) or placebo group. The drugs were bolus at 0.5mcg/kg in 20 minutes and infused at 0.4 mcg/kg/hruntil the end of the operation. Anesthetic and surgical technique was similar in both groups. Serum creatinine, plasma NGAL and urine NGAL were collected and compared at 0,6,24 hours.
Results: Total of 20 patients were enrolled and randomized into dexmed group (n = 10) and control group (n = 10). There were no differences in patient characteristic data. Serum creatinine and urinary NGAL at 6 and 24 hours were not significantly different between groups. Plasma NGAL in dexmed group was significantly less than control group at 6 and 24 hours (149.5 vs 291.4; p = 0.016 and 118.5 vs 201.5; p = 0.004). Moreover, dexmed group had significantly higher urine output throughout the operation (4.5 vs 2.4 ml/kg/hr.; p = 0.011). At 24 hours, we found AKI in 3 patients in the control group butnone in the dexmedgroup(p = 0.06).
Conclusion: We demonstrated that dexmedetomidine reduced AKI in elective CABG patients when using NGAL as a biomarker.We also found that dexmedetomidine helps promoting urine output.
Article Details
Copyright
Copyright of all articles published in the Thai Journal of Anesthesiology is held by the Thai Journal of Anesthesiology, the Royal College of Anesthesiologists of Thailand. Submission of a manuscript constitutes the authors' agreement that, upon acceptance for publication, copyright of the work is transferred to the Journal. The content and any opinions expressed in published articles are the sole responsibility of the authors and do not necessarily reflect the views of the editorial board or the Royal College of Anesthesiologists of Thailand.
Licensing
All articles are published open access under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). Under this license, anyone may copy and redistribute published articles in any medium or format for non-commercial purposes, provided that appropriate credit is given to the authors and to the Thai Journal of Anesthesiology as the original source of publication, a link to the license is included, and the material is not modified in any way. Requests for commercial use or for adaptation of published material should be directed to the editorial office.
Authors' Rights
Although copyright is held by the Journal, authors retain the right to reuse their own published material in their future scholarly works, theses and dissertations, teaching, and academic presentations, and to deposit the final published version (PDF) in institutional or subject repositories or on personal and institutional websites, without embargo, provided that the Thai Journal of Anesthesiology is clearly acknowledged as the original place of publication.
